Evaluation Technical Assistance for NYHealth Grantees, Phases 8 & 9

Many grantees, especially smaller, non-academic organizations, often lack the experience, time, and resources needed to conduct and implement evaluations that are critical to effective program execution and sustainability.

Grantee Name

New York University School of Medicine

Funding Area

Other

Publication Date

August 2019

Grant Amount

$297,850

Grant Date:

November 2016 – October 2017
November 2017 – October 2018

Other

Many grantees, especially smaller, non-academic organizations, often lack the experience, time, and resources needed to conduct and implement evaluations that are critical to effective program execution and sustainability.

To address this need among its own grantees, NYHealth began funding in 2008 a technical assistance initiative that offers additional support to grantees in strengthening the evaluation aspects of their projects. Under Phase 1 and 2 of this grant, the Center for Health Care Strategies led the project; beginning in 2011, an evaluation team from the New York University School of Medicine has overseen the initiative. The evaluation team has been providing direct assistance to grantees; holding training workshops for grantees; and offering one-on-one follow-up assistance to workshop participants. An online evaluation resource is also available for potential NYHealth applicants.

Because of the success of the initiative, NYHealth continues to provide technical assistance for new grantees and applicants each year.

Outcomes and Lessons Learned

  • Reached out to all new and eligible grantees to review the type of assistance needed;
  • In 2016–17, provided individualized assistance to 17 grantee organizations;
  • In 2017–18, provided individualized assistance to 13 grantee organizations; and
  • Conducted two workshops on evaluation topics for participants during each grant phase, one in January and the other in June.

Related Grants:

Phases 1 & 2: $253,635 and $220,301
Phases 3 & 4: $166,979 and $151,670
Phases 5 & 6: $148,297 and $149,553
Phase 10: $163,005

Co-Funding and Additional Funds Leveraged: N/A